3-Bromo-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazine

Catalog No. :
ACLRAY235
CAS No. :
1393558-10-5
Molecular Formula :
C6H7BrN2O
Molecular Weight :
203.04

IUPAC Name:3-bromo-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazine

3-Bromo-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$324.00Login to see priceIn stockInquiry
250mg95%$540.00Login to see priceIn stockInquiry
500mg95%$774.00Login to see priceIn stockInquiry
1g95%$1155.00Login to see priceIn stockInquiry
5g95%$3280.00Login to see priceIn stockInquiry
10g95%$4998.00Login to see priceIn stockInquiry
25g95%$9995.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazine
IUPAC Name3-bromo-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazine
MDL No.MFCD22544039
Molecular FormulaC6H7BrN2O
Molecular Weight203.04
SMILESBrC1=C2COCCN2N=C1
InChI KeyVUYWLEYGTFTTMN-UHFFFAOYSA-N
Synonym3-BROMO-6,7-DIHYDRO-4H-PYRAZOLO[5,1-C][1,4]OXAZINE | 1393558-10-5 | SCHEMBL19432127 | MFCD22544039 | AB77061 | AS-79610 | SY312415 | 3-Bromo-1H-pyrazolo[5,1-c][1,4]oxazine | P20387
CAS No.1393558-10-5
PubChem CID72214585

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACLRAY235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLRAY235 route product structure diagram
    ACLRAY2351393558-10-5 In Stock
Inquiry

2. ACLRAY235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLRAY235 route product structure diagram
    ACLRAY2351393558-10-5 In Stock
Inquiry

Comments (0)